Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions

References

• WHO/CDCWorldwide Prevalence of Anemia 1993–2005: WHO Global Database on AnemiaGeneva, SwitzerlandWHO Press2008
   Google Scholar
• MillerJLIron deficiency anemia: a common and curable diseaseCold Spring Harb Perspect Med201337a01186623613366
   PubMed Web of Science ®Google Scholar
• FordDCDahlNVStraussWEFerumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disordersClin Exp Gastroenterol2016915116227468245
   PubMedGoogle Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO)KDIGO clinical practice guideline for anemia in chronic kidney diseaseKidney Int Suppl201224280335
   Google Scholar
• MacdougallICBircherAJEckardtKUIron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) controversies conferenceKidney Int2016891283926759045
   PubMed Web of Science ®Google Scholar
• MacdougallICVernonKComplement activation-related pseudo-allergy: a fresh look at hypersensitivity reactions to intravenous ironAm J Nephrol2017451606227894115
   PubMed Web of Science ®Google Scholar
• SampsonHAMunoz-FurlongACampbellRLSecond symposium on the definition and management of anaphylaxis: summary report – Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network SymposiumJ Allergy Clin Immunol2006117239139716461139
   PubMedGoogle Scholar
• JohanssonSGBieberTDahlRRevised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003J Allergy Clin Immunol2004113583283615131563
   PubMed Web of Science ®Google Scholar
• LiebermanPKempSFOppenheimerJLangDMBernsteinILNicklasRAThe diagnosis and management of anaphylaxis: an updated practice parameterJ Allergy Clin Immunol20051153 suppl 2S483S52315753926
   PubMed Web of Science ®Google Scholar
• LiebermanPNicklasRARandolphCAnaphylaxis – a practice parameter update 2015Ann Allergy Asthma Immunol2015115534138426505932
   PubMed Web of Science ®Google Scholar
• HempelJCPoppelaarsFGaya da CostaMDistinct in vitro complement activation by various intravenous iron preparationsAm J Nephrol2017451495927889746
   PubMed Web of Science ®Google Scholar
• SzebeniJComplement activation-related pseudoallergy: a new class of drug-induced acute immune toxicityToxicology20052162–310612116140450
   PubMed Web of Science ®Google Scholar
• BircherAJAuerbachMHypersensitivity from intravenous iron productsImmunol Allergy Clin North Am201434370772325017687
   PubMed Web of Science ®Google Scholar
• BlazevicAHunzeJBootsJMSevere hypophosphataemia after intravenous iron administrationNeth J Med2014721495324457442
   PubMed Web of Science ®Google Scholar
• ManiLYNseirGVenetzJPPascualMSevere hypophosphatemia after intravenous administration of iron carboxymaltose in a stable renal transplant recipientTransplantation201090780480520881582
   PubMed Web of Science ®Google Scholar
• SatoKNohtomiKDemuraHSaccharated ferric oxide (SFO)-induced osteomalacia: in vitro inhibition by SFO of bone formation and 1,25-dihydroxy-vitamin D production in renal tubulesBone199721157649213008
   PubMed Web of Science ®Google Scholar
• SatoKShirakiMSaccharated ferric oxide-induced osteomalacia in Japan: iron-induced osteopathy due to nephropathyEndocr J19984544314399881891
   PubMed Web of Science ®Google Scholar
• SchoutenBJDoogueMPSouleSGHuntPJIron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalaciaAnn Clin Biochem200946pt 216716919151167
   PubMed Web of Science ®Google Scholar
• Van WyckDBMangioneAMorrisonJHadleyPEJehleJAGood-noughLTLarge-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trialTransfusion200949122719272819682342
   PubMed Web of Science ®Google Scholar
• OnkenJEBregmanDBHarringtonRAA multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemiaTransfusion201454230631523772856
   PubMed Web of Science ®Google Scholar
• SchaeferBWurtingerPFinkenstedtAChoice of high-dose intravenous iron preparation determines hypophosphatemia riskPLoS One20161112e016714627907058
   PubMed Web of Science ®Google Scholar
• Mannheim J [webpage on the Internet]Hypophosphatemia2014 Available from: https://medlineplus.gov/ency/article/000307.htmAccessed March 11, 2017
   Google Scholar
• AnandGSchmidCSevere hypophosphataemia after intravenous iron administrationBMJ Case Rep20172017
   Google Scholar
• SchoutenBJHuntPJLiveseyJHFramptonCMSouleSGFGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective studyJ Clin Endocrinol Metab20099472332233719366850
   PubMed Web of Science ®Google Scholar
• WolfMKochTABregmanDBEffects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in womenJ Bone Miner Res20132881793180323505057
   PubMed Web of Science ®Google Scholar
• GanguliAKohliHSJhaVGuptaKLSakhujaVThe comparative safety of various intravenous iron preparations in chronic kidney disease patientsRen Fail200830662963818661414
   PubMed Web of Science ®Google Scholar
• HetzelDStraussWBernardKLiZUrbonieneAAllenLFA phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapyAm J Hematol201489664665024639149
   PubMed Web of Science ®Google Scholar
• KoschMBahnerUBettgerHMatzkiesFTeschnerMSchaeferRMA randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpoNephrol Dial Transplant20011661239124411390726
   PubMed Web of Science ®Google Scholar
• MacdougallICStraussWEMcLaughlinJLiZDellannaFHertelJA randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKDClin J Am Soc Nephrol20149470571224458078
   PubMed Web of Science ®Google Scholar
• SavTTokgozBSipahiogluMHIs there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran?Ren Fail200729442342617497463
   PubMed Web of Science ®Google Scholar
• SheashaaHEl-HusseiniASabryAParenteral iron therapy in treatment of anemia in end-stage renal disease patients: a comparative study between iron saccharate and gluconateNephron Clin Pract2005994c97c10115692217
   PubMedGoogle Scholar
• AiryMMandayamSMitaniAAComparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patientsNephrol Dial Transplant201530122068207526311216
   PubMed Web of Science ®Google Scholar
• WangCGrahamDJKaneRCComparative risk of anaphylactic reactions associated with intravenous iron productsJAMA2015314192062206826575062
   PubMed Web of Science ®Google Scholar
• WetmoreJBWeinhandlEDZhouJGilbertsonDTRelative incidence of acute adverse events with ferumoxytol compared to other intravenous iron compounds: a matched cohort studyPLoS One2017121e017109828135334
   PubMed Web of Science ®Google Scholar